Acceleron (XLRN) in Focus: Stock Moves 5.3% Higher

Acceleron Pharma Inc. XLRN was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $90.94 – $108.55 in the past one-month time frame, witnessed a sharp increase on Friday.

The company has seen one positive estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Acceleron. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Acceleron currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Acceleron Pharma Inc. Price

Acceleron Pharma Inc. Price

Acceleron Pharma Inc. price | Acceleron Pharma Inc. Quote

A better-ranked stock in the Medical sector is BioLineRx Ltd. BLRX, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Hottest Tech Mega-Trend of All

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
BioLineRx Ltd. (BLRX) : Free Stock Analysis Report
 
Acceleron Pharma Inc. (XLRN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research